Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.
The decision seemed straightforward. Bob McHenry's heart was failing, and doctors recommended two high-risk surgeries to restore blood flow. Without the procedures, McHenry, 82, would die.
Less-invasive procedures to open severely-clogged leg arteries were as good at helping people survive and avoid amputation as more invasive open surgeries, according to a study reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.
Noninvasive device could benefit patients with kidney disease, congestive heart failure, or dehydration.
Older adults are more vulnerable to fractures due to bone mass loss. Hip fractures can be tremendously grave, often leading to chronic disease and even death. Now, experts from the American Geriatrics Society explain the true toll of hip fractures and how older adults fare up after the injury.
Cheryl Krafft was diagnosed with an aggressive form of non-Hodgkin's lymphoma and was put on a very high-powered chemotherapy regimen to rid her body of the cancer. What she was not counting on was the chemotherapy causing another equally deadly problem.
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate that remission in patients with rheumatoid arthritis is associated with an 80% reduction in risk of cardiovascular outcomes.
Genetic variation in heart valve cells of the developing fetus create the blueprint for the later development of mitral valve prolapse, according to the cover story of today's Science Translational Medicine.
Noonan Syndrome is a rare genetic syndrome typically evident at birth and often linked to early-onset severe heart disease.
Researchers at University of California San Diego School of Medicine found that using blood thinners in patients with worsening heart failure, coronary artery disease or irregular heart rhythms was associated with a 17 percent reduced risk of thromboembolic events, such as stroke and heart attack.
Doctors know they're the sounds of lung problems, but it turns out they might be more than symptoms--crackling and wheezing could be the sounds of a disease progressing, a University of Michigan researcher has found.
When Larry Anders moved into the Bay at Burlington nursing home in late 2017, he wasn't supposed to be there long. At 77, the stoic Wisconsin machinist had just endured the death of his wife of 51 years and a grim new diagnosis: throat cancer, stage 4.
Although the majority of patients who have blood cancers are older adults, they make up only a small percentage of participants in the clinical trials that lead to new therapies.
After they amputated the second toe on John Trumbla's right foot last summer, doctors sent him to a nursing home because he still needed medical care — but not necessarily a hospital bed.
As the U.S. population ages, hospitals and health systems around the country have been grappling with how to integrate advance care planning into routine practice.
Parents who have five or more children may face a higher risk of heart disease than those who have only one or two keiki, according to new findings by public health researchers in the Myron B. Thompson School of Social Work at the University of Hawaii at Manoa.
With 1 million new cases of congestive heart failure diagnosed each year, a revolutionary product is making it easier for hospitals to monitor patients with the condition in the comfort of their own homes.
Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.
Thousands of patients with congestive heart failure benefit from automatic implantable cardiac defibrillators that deliver shocks to the heart to correct abnormal heart rhythms. These defibrillators improve survival in patients who are at risk for sudden cardiac death.
In the year following placement of a CardioMEMS heart failure sensor—designed to wirelessly measure and monitor pulmonary artery pressures that can signal worsening heart failure—patients experienced a 58 percent reduction in hospitalization for heart failure, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. Reductions in hospitalizations were seen in both men and women, across all ejection fraction ranges and regardless of race.
New research shows that U.S. safety net hospitals could benefit substantially from a new model that accounts for social risk factors like poverty and living in a disadvantaged neighborhood in determining how the federal government penalizes hospitals financially for their readmission rates.